3 Matching Annotations
  1. Aug 2022
  2. www.nature.com www.nature.com
    Optimization of Non-Coding Regions for a Non-Modified mRNA COVID-19 Vaccine
    1
    1. jackiekrauss 29 Aug 2022

      Gebre, M. S., Rauch, S., Roth, N., Yu, J., Chandrashekar, A., Mercado, N. B., He, X., Liu, J., McMahan, K., Martinot, A., Martinez, D. R., Giffin, T., Hope, D., Patel, S., Sellers, D., Sanborn, O., Barrett, J., Liu, X., Cole, A. C., … Barouch, D. H. (2021). Optimization of Non-Coding Regions for a Non-Modified mRNA COVID-19 Vaccine. Nature, 1–8. https://doi.org/10.1038/s41586-021-04231-6

      is:preprint lang:en COVID-19 vaccine mRNA vaccine efficacy optimized non-coding region non-modified nucleoside immunogenicity nonhuman primate neutralizing antibody response protective efficacy
    Visit annotations in context

    Tags

    Annotators

    URL

    nature.com/articles/s41586-021-04231-6
  3. Jul 2021
  4. www.biorxiv.org www.biorxiv.org
    https://biorxiv.org/cgi/content/10.1101/2021.07.19.452771
    1
    1. Lu17Cheryl 29 Jul 2021

      Tada, Takuya, Hao Zhou, Marie I. Samanovic, Belinda M. Dcosta, Amber Cornelius, Mark J. Mulligan, and Nathaniel R. Landau. “Comparison of Neutralizing Antibody Titers Elicited by MRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants.” BioRxiv, July 19, 2021, 2021.07.19.452771. https://doi.org/10.1101/2021.07.19.452771.

      is:preprint lang:en COVID-19 Coronavirus pandemic SARS-CoV-2 variant neutralizing-antibody response vaccine efficacy mRNA vaccine adenoviral vector-based vaccine Delta variant Beta variant Delta plus variant Lambda variant surveillance
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2021.07.19.452771v2
  5. Mar 2021
  6. jamanetwork.com jamanetwork.com
    Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination
    1
    1. Lu17Cheryl 21 Mar 2021

      Edara, Venkata Viswanadh, William H. Hudson, Xuping Xie, Rafi Ahmed, and Mehul S. Suthar. “Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination.” JAMA, March 19, 2021. https://doi.org/10.1001/jama.2021.4388.

      is:article lang:en COVID-19 pandemic antibody vaccination SARS-CoV-2 variant neutralizing-antibody response mutation infection immunity
    Visit annotations in context

    Tags

    Annotators

    URL

    jamanetwork.com/journals/jama/fullarticle/2777898